Fukuda, Hiroki
Suwa, Hideaki
Nakano, Atsushi
Sakamoto, Mari
Imazu, Miki
Hasegawa, Takuya
Takahama, Hiroyuki
Amaki, Makoto
Kanzaki, Hideaki
Anzai, Toshihisa
Mochizuki, Naoki
Ishii, Akira
Asanuma, Hiroshi
Asakura, Masanori
Washio, Takashi
Kitakaze, Masafumi
Article History
Received: 8 July 2016
Accepted: 24 October 2016
First Online: 15 November 2016
Competing interests
: Relationships to industry do not exist for H.F., H.S., A.N., M.S., M.I., H.T., M.A., H.K., T.A., N.M., A.I., H.A., and T.W. T.H. reports personal fees from Takeda, Daiichi-Sankyo, Otsuka, Bayer, Tanabe-Mitsubishi, Abbott Vascular Japan, Shionogi. M.A. reports grants from government during the conduct of the study; personal fees and non-financial support from Pfizer, personal fees from Boeringer-Ingerheim, Tanabe-Mitsubishi, Kowa and Takeda. M.K. reports grants from Japanese government, grants from Japan Heart Foundation, grants from Japan Cardiovascular Research Foundation, grants and personal fees from Takeda, Astellas, Sanofi, Pfizer, Novartis, Bheringer-Ingerheim, Tanabe-mitubishi, Kyowa-hakko-kirin, Abott, and Otsuka outside the submitted work; personal fees from Daiichi-sankyo, Ono, Bayer, from Kowa, Dainihon-sumitomo, Sawai, MSD, Calpis, Shionogi, Astrazeneca, Asahikasei Med., Novo Nordisk, Fuji-film RI, and Japan Medical Data, outside the submitted work; grants from Nihon Kohden.